Robert W. Baird Trims Molina Healthcare (NYSE:MOH) Target Price to $331.00

Molina Healthcare (NYSE:MOH) had its target price decreased by equities researchers at Robert W. Baird from $405.00 to $331.00 in a research note issued on Thursday, Benzinga reports. The firm presently has an “outperform” rating on the stock. Robert W. Baird’s price objective indicates a potential upside of 20.48% from the company’s previous close.

Several other research firms have also weighed in on MOH. Wells Fargo & Company raised their price objective on Molina Healthcare from $315.00 to $360.00 and gave the company an “equal weight” rating in a research note on Monday, August 5th. StockNews.com raised Molina Healthcare from a “hold” rating to a “buy” rating in a research note on Friday, October 18th. Stephens reaffirmed an “equal weight” rating and issued a $320.00 price objective on shares of Molina Healthcare in a research note on Thursday, July 25th. Jefferies Financial Group reduced their price objective on Molina Healthcare from $354.00 to $297.00 and set a “hold” rating on the stock in a research note on Wednesday, July 24th. Finally, Truist Financial cut their price target on Molina Healthcare from $440.00 to $400.00 and set a “buy” rating on the stock in a research note on Monday, July 15th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $371.83.

Molina Healthcare Stock Down 3.3 %

Shares of NYSE MOH opened at $274.73 on Thursday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.57 and a current ratio of 1.57. Molina Healthcare has a 52 week low of $272.69 and a 52 week high of $423.92. The stock has a market capitalization of $16.10 billion, a P/E ratio of 14.91, a PEG ratio of 1.15 and a beta of 0.58. The stock’s fifty day moving average is $336.17 and its 200 day moving average is $330.51.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings data on Wednesday, July 24th. The company reported $5.86 earnings per share for the quarter, beating the consensus estimate of $5.73 by $0.13. The business had revenue of $9.88 billion for the quarter, compared to analyst estimates of $9.75 billion. Molina Healthcare had a return on equity of 28.09% and a net margin of 2.84%. Molina Healthcare’s revenue was up 18.7% compared to the same quarter last year. During the same period last year, the firm posted $5.65 earnings per share. Sell-side analysts forecast that Molina Healthcare will post 23.5 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Steven J. Orlando sold 1,000 shares of the business’s stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total transaction of $339,210.00. Following the completion of the sale, the director now owns 18,025 shares in the company, valued at $6,114,260.25. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In related news, CAO Maurice Hebert sold 393 shares of Molina Healthcare stock in a transaction that occurred on Thursday, August 15th. The stock was sold at an average price of $346.52, for a total transaction of $136,182.36. Following the transaction, the chief accounting officer now owns 9,473 shares of the company’s stock, valued at $3,282,583.96. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Steven J. Orlando sold 1,000 shares of Molina Healthcare stock in a transaction that occurred on Tuesday, July 30th. The shares were sold at an average price of $339.21, for a total value of $339,210.00. Following the transaction, the director now directly owns 18,025 shares in the company, valued at approximately $6,114,260.25. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.10% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the stock. Innealta Capital LLC purchased a new position in Molina Healthcare in the second quarter worth $36,000. Ashton Thomas Private Wealth LLC purchased a new position in Molina Healthcare in the second quarter worth $40,000. AM Squared Ltd purchased a new position in Molina Healthcare in the second quarter worth $59,000. UMB Bank n.a. boosted its position in Molina Healthcare by 96.2% in the third quarter. UMB Bank n.a. now owns 206 shares of the company’s stock worth $71,000 after purchasing an additional 101 shares during the last quarter. Finally, Fidelis Capital Partners LLC purchased a new position in Molina Healthcare in the first quarter worth $151,000. Hedge funds and other institutional investors own 98.50% of the company’s stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.